Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Albuterol-HFA-BAI vs MDI in Asthmatics with Poor Coordination
NCT00530062Phase 4Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Jul 2007
- Primary completion
- Oct 2008
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of albuterol dry powder inhaler in asthma (2 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoint: Area-Under-the-Effect Curve of Percent Change in Test-Day Baseline Forced Expiratory Volume in 1 Second (FEV1) Versus Time (up to 2 Hours Postdose). Started Jul 2007; status: completed.
02
Drugs
albuterol dry powder inhaler
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00530062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00530062.